Delivery Order SPE2DB22D3501-SPE2DB25FVN59
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price delivery order was competitively awarded without set-aside designation and is set for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This competitively awarded, firm fixed-price delivery order is set to be completed by June 30, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract is classified as a non-set-aside procurement, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Abilify Maintena ER 400 mg vials with a ceiling value of $1,843.01. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,305.05 by the Defense Logistics Agency on August 28, 2025, for the supply of Abilify Maintena ER 400 mg syringes. The contract is firm fixed price with an ultimate completion date of August 29, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,438.27 for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate headquarters operates. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,842.17 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with performance at the contractor's Conshohocken, Pennsylvania headquarters and completion scheduled for September 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The award reflects the contractor's role as a critical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,731.25 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4,564,248,487 units of Abilify Maintena ER 400 mg syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $4,992.00 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes, with an ultimate completion date of September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes under a firm fixed-price contract with a ceiling value of $2,287.19. Awarded on September 23, 2025, this non-set-aside delivery order is scheduled for completion by September 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the company's broader...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVN59Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. The contract, awarded on May 5, 2025, with a completion date of May 6, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly fulfills delivery orders for specialized medications and medical supplies through its DLA prime contract vehicle. This particular order for Abilify Maintena, an antipsychotic medication, reflects the company's ongoing role in supporting the Defense Health Agency and other military healthcare systems with specialty pharmaceuticals across multiple therapeutic domains. The minimal order value and expedited completion timeline suggest this represents a routine fulfillment under the broader IDC framework that governs the company's pharmaceutical supply relationship with the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/5/25 |